Prostascint Trademark Details

Prostascint was registered on Tuesday, September 22, 2009 and is currently owned by Jazz Pharmaceuticals, Inc. under the registration number 3687447 . This mark is alive with a status of Section 8 & 15-Accepted and Acknowledged. The last case file activity for this mark occured 9 years ago on Tuesday, April 7, 2015, according to the United State Patent & Trademark Office
Word Mark Prostascint
Status Alive Registered 702 — Section 8 & 15-Accepted and Acknowledged

Current Owner

Jazz Pharmaceuticals, Inc. of Palo Alto, CA

View all trademarks for Jazz Pharmaceuticals, Inc.
Other Trademarks for Jazz Pharmaceuticals, Inc.

Previous Owners

Eusa Pharma (USA), Inc. of Langhorne, PA

View all trademarks for Eusa Pharma (USA), Inc.
Other Trademarks for Eusa Pharma (USA), Inc.

Cytogen Corporation of Princeton, NJ

View all trademarks for Cytogen Corporation
Other Trademarks for Cytogen Corporation
Serial Number 78410517
Registration Number 3687447
Status Date Tuesday, April 7, 2015
Filing Date Tuesday, April 7, 2015
Registration Date Tuesday, September 22, 2009
Attorney Stephen R. Baird

Correspondent

Stephen R. Baird
WINTHROP & WEINSTINE, P.A.
Capella Tower, Suite 3500
225 South Sixth Street
Minneapolis MN 55402

Case File Statements

Indication of Colors Color is not claimed as a feature of the mark.
Goods & Services Pharmaceutical preparations, namely, radioimmuno-scintigraphy agents used to diagnose and treat cancerous tumors

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Thursday, May 6, 2004
First Use Anywhere Sunday, June 1, 2008
First Use In Commerce Sunday, June 1, 2008
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.